![]() |
|
|
Vol. 286, Issue 1, 509-518, July 1998
-Aminobutyric Acid Receptor-Mediated Hyperpolarization
Recorded from the Dorsolateral Septum1
Department of Pharmacology and Toxicology, University of Texas Medical Branch at Galveston, Galveston, Texas
| |
Abstract |
|---|
|
|
|---|
Previous reports of membrane hyperpolarizations, associated with
acute application of cocaine, have been recorded from brain slice
preparations containing aminergic nuclei and have always been
attributed to cocaine's ability to elevate levels of local biogenic
amines followed by activation of their receptors. The majority of these
studies were conducted with brain slices obtained from rats that had
not received prior chronic in vivo treatment with
cocaine. We observed that cocaine alone, at 3 µM, could induce a
membrane hyperpolarization (COC-HYP) in 100% of rat dorsolateral septal nucleus (DLSN) neurons from brain slices of rats treated chronically with cocaine for either 14 or 28 days in
vivo. The DLSN is a nucleus absent of biogenic amine cell
bodies, but does contain biogenic amine terminals with GABAergic cell
bodies and terminals. Cocaine applied to brain slices from rats not
previously administered cocaine or administered cocaine for up to seven
days in vivo yielded a maximum incidence of COC-HYPs at
only 50%. COC-HYPs recorded from DLSN neurons were not blocked by
previous treatment with amine receptor antagonists or by a TTX and zero
calcium medium. Based on these results, the ability of DLSN neurons to
respond to a cocaine challenge with a COC-HYP did not involve
inhibition of amine reuptake/uptake or action potential release of
neuroactive substances. Rather, the COC-HYP, with an apparent reversal
potential of -80 mV, was reduced by the GABA receptor
antagonists-bicuculline and CGP-55845A. Lowering extracellular
Na+ or Cl
, lowering of
temperature, or previous superfusion with the GABA uptake blocker
NO-711 could block the COC-HYP. In summary, our data suggest that
COC-HYPs, after application of a cocaine challenge to brain slices from
rats treated chronically (14 - 28 days, but not acutely, 7 days) with
cocaine are due to cocaine-induced changes in GABA release and/or
transporter function. The latter changes in transporter function may
involve the reversal of the GABA transporter with release of GABA and
subsequent activation of postsynaptic GABAA and
GABAB receptors.
| |
Introduction |
|---|
|
|
|---|
The
majority of studies to determine the cellular actions of cocaine
in vitro has used CNS synapses of drug naive rats. These synapses have included both aminergic cell body regions and their terminal fields. There has been a remarkable consistency in terms of
the responses obtained after administration of cocaine to aminergic cell body regions. That is, when cocaine alone is applied and recordings are made from cell body areas, a significant inhibitory effect, e.g., a membrane hyperpolarization is recorded
from biogenic amine-containing neurons. This membrane
hyperpolarization associated with acute cocaine application results
from a potentiation of the typical actions of the transmitter released
endogenously (Suprenant and Williams, 1987
; Pan and Williams, 1989
;
Lacey et al., 1990
; Bonci and Williams, 1996
). In general,
the ability of cocaine to potentiate biogenic amine responses has been
attributed to its well-known action to bind to the respective amine
transporters (Ross and Renyi, 1969
; Ritz et al., 1987
).
Subsequently, inhibition of the transporter would inhibit uptake of
biogenic amines applied exogenously to the slice or block reuptake of
endogenous biogenic amines released within an aminergic synapse.
However, in brain areas lacking biogenic amine-containing somata,
i.e., terminal field areas, responses to cocaine
administration have varied from alterations of membrane potential,
modification of synaptic activity or no effect (Jahromi et
al., 1993
; Simms and Gallagher, 1996
). Although the effects of
cocaine when administered alone have been equivocal, cocaine would
potentiate the actions of exogenously applied biogenic amines or
prolong evoked aminergic synaptic potentials (Uchimura and North, 1990
;
Bobker and Williams, 1991
; Jahromi et al., 1993
; Simms and
Gallagher, 1996
).
The DLSN is a biogenic amine terminal area and one that contains a very
high density of cell bodies and terminals for inhibitory (GABA) and
excitatory (glutamate) amino acids (Jakab and Leranth, 1994
). Because
its synaptic pathways contain a diversity of receptors (Gallagher
et al., 1995
), and its implication in emotion and anxiety (Gray, 1982
), we chose the DLSN to investigate the multiple actions of
cocaine (Woolverton and Johnson, 1992
).
Furthermore, because cocaine dependence is a process that is
essentially chronic in nature, studies of the effects of repeated cocaine administration in animals are required to suggest a possible interpretation of the clinical effects of chronic cocaine
administration in humans. For instance, although cocaine initially
produces euphoria and mood elevation, continued abuse can lead to
psychiatric problems such as anxiety, depression and psychosis
(Fischman, 1987
). Accordingly, it has become especially important to
study the cellular mechanism(s) by which chronic cocaine in
vivo affects neural function both prior to and after an acute
"cocaine challenge" or reexposure to cocaine in vitro.
We had initially examined the acute in vitro actions of
cocaine (Simms and Gallagher, 1993
; Simms et al., 1994
)
applied to brain slice preparations from rats pretreated with saline or
not pretreated with cocaine in vivo. Data from these
experiments were similar to those reported by Jahromi et al.
(1993)
. These investigators recorded from multiple biogenic amine
terminal areas and observed a variety of effects after an acute
application of cocaine. However, like us, none of their effects were
significant statistically. No consistent changes were reported in any
of the following parameters: resting membrane potential, input
resistance or spontaneous and evoked inhibitory and excitatory synaptic
activity.
However, after a 14-day, but not 7-day, in vivo exposure to
cocaine (15 mg/kg, twice daily) we observed that all of the above properties were altered significantly and consistently (Shoji et
al., 1997
: figs. 1 and 2). Furthermore, we also demonstrated (Simms and Gallagher, 1997
) that after the same 14-day, but not 7-day,
chronic treatment with cocaine, the distribution of cell types within
the DLSN (Gallagher et al., 1995
) differed with chronic cocaine exposure. All of the changes we have reported before occurred in the absence of any additional acute drug treatment, and thus represented the chronic effects of cocaine to alter the intrinsic electrical and synaptic properties of DLSN neurons (Simms and Gallagher, 1996
; 1997
; Shoji et al., 1997
).
Our study was undertaken to characterize the cellular response to a "challenge" dose of cocaine in vitro 16 hr after chronic periods of intermittent cocaine exposure in vivo.
| |
Materials and Methods |
|---|
|
|
|---|
Cocaine treatment regimen.
Male Sprague-Dawley rats (Harlan,
75-250 g) were housed three to four per cage with free access to food
and water. Each rat received injections with either saline (0.9%) or
cocaine HCl [Sigma Chemical Co., St. Louis, MO or National Institute
on Drug Abuse (NIDA), Rockville, MD] [15 mg/kg, i.p., twice daily
(9:00 A.M. and 4:00 P.M.)] for 7 (COC-7), 14 (COC-14) or 28 (COC-28) consecutive days. It is well established that
behavioral sensitization can develop to locomotor activity and
stereotyped behavior, specifically, rearing, fast repetitive head
and/or foreleg movement, induced by cocaine when it is administered
intermittently (Post, 1977
). We used the development of behavioral
sensitization to cocaine as an indicator of the effectiveness of our
cocaine injections. Behavioral sensitization was measured as enhanced
exploratory locomotor activity and induced stereotypic behavior in all
animals 15 min after twice daily treatment with cocaine for periods of either 7, 14 or 28 days (see Simms and Gallagher, 1996
).
Preparation of brain slice.
Rat forebrain coronal slices
(500-µm thick) containing the DLSN were prepared using standard
techniques (Stevens et al., 1984
). Briefly, the rat was
decapitated and the brain rapidly removed and immersed in a modified
cold ACSF solution. The ACSF solution was maintained at 6°C and
bubbled continuously with 95% O2 and 5%
CO2 to maintain proper pH (7.3-7.4). The
composition of the ACSF solution was as follows: NaCl, 117 mM; KCl, 4.7 mM; NaH2PO4, 1.2 mM;
MgCl2, 1.2 mM; CaCl2, 2.5 mM; NaHCO3, 25 mM and glucose, 11.5 mM. In the
cold (6°C) solution, the brain was quickly blocked to transverse
sections 2-mm thick with the caudal edge at the level of the optic
chiasm. Diagonal cuts were then made lateral to the anterior commissure
to remove most of the cortex and striatum. The resulting block of
tissue was glued (Duro Super Glue, Loctite Corp., Rocky Hill, CT) to a
chuck and placed in the bath of a Vibroslice (752 M, Campden
Instruments, Ltd., London, England, UK) in similarly treated cold ACSF
solution. Serial slices were made rostral to caudal until a section
containing medial and lateral septal nuclei was produced. The slice was
then placed in a superfusion chamber maintained at 32 ± 2°C and
superfused at a flow rate of 1 to 1.5 ml/min with ACSF solution bubbled
continuously with 95% O2 and 5%
CO2. We routinely use the following two criteria
as indices of viable slices. First, stable MP of at least -50 mV must
be maintained for at least 10 min. Second, the neurons must respond to
direct positive current stimulation with a rapid and overshooting
sodium spike.
Recording from brain slice.
Sharp intracellular recordings
were obtained using Frederick-Haer standard wall 1.0-mm fiber filled
glass microelectrodes pulled to final tip resistances of 70 to 100 M
and filled with 2 M potassium acetate. Ri was routinely measured by
passing hyperpolarizing current pulses of known intensities through the
recording electrode using a bridge-type circuit. Voltage signals and
applied current were recorded with an Axoclamp 2A amplifier (Axon
Instruments, Inc., Foster City, CA). The output of the amplifier was
D.C. coupled to a storage oscilloscope (Model 5111, Tektronix,
Portland, OR) and a dual channel Gould (Cleveland, OH) (Model 220)
chart recorder. A Model 4208 Panasonic VCR/Recorder (A.R. Vetter Co.,
Rebersburg, PA) was used to capture all tracings for storage. The
stored signal can be played back and analyzed using a pClamp Version
6.0 Software with a DigiData 1200 interface to a Gateway 2000 4DX2-66V
computer. Paper copies of the waveforms were generated with a Hewlett
Packard Laserjet 4 printer.
Electrical stimulation of brain slice.
In some experiments
the brain slice was stimulated electrically to yield low frequency
induced orthodromic responses via outputs from a Grass (Quincy, MA)
S-88 stimulator with isolation units. Focal stimulation was applied
through a low resistance concentric bipolar electrode (Frederick-Haer)
inserted into the dorsolateral aspect of the DLSN nucleus of the
septum. Stimulus parameters were adjusted to yield consistent
responses, e.g., 100-µsec duration and 1 to 10 V
intensity, at a frequency of 0.17 Hz. We have demonstrated previously
that neurons in the DLSN display a series of synaptic potentials in the
slice preparation after electrical stimulation of fimbrial afferents
and/or local interneurons. These include: 1) an excitatory amino acid-
(probably glutamate) mediated EPSP that results from activation of both
non-NMDA and NMDA (N-methyl-D-aspartic acid) receptors
(Gallagher and Hasuo, 1989
); 2) a f-IPSP-mediated by GABA acting at
GABAA receptors (Stevens et al., 1984
)
and 3) a s-IPSP-mediated, at least in part, by GABA acting at
GABAB receptors (Hasuo and Gallagher, 1988
).
Drug application. Pharmacological sensitivity and drug testing were carried out by superfusion of known concentrations of substances. Substances were dissolved in the ACSF and entered the recording chamber through a gravity feed inlet of the superfusion system. All drug stock solutions were made up in distilled H2O. The drugs used in the these experiments were as follows: (-)-bicuculline methiodide and TTX from Sigma; (±) sulpiride, idazoxan HCl, CPT; atropine sulfate; p-MPPF dihydrochloride; NO-711-HCl, and D-AP5 from Research Biochemicals Incorporated (RBI, Natick, MA); CGP-55845A from Ciba-Geigy (Basel, Switzerland); CNQX from Tocris-Cookson (Essex, UK); (-)-cocaine HCl from Sigma and the National Institute on Drug Abuse (NIDA).
Data analysis.
Cocaine was applied by superfusion to the
slice and a change in membrane potential was recorded intracellularly.
We chose to superfuse routinely and primarily with 3 µM cocaine
because our preliminary results showed this concentration of cocaine
produced consistent hyperpolarizations and was incapable of local
anesthetic effects such as increasing the threshold or width of a
sodium spike induced by positive current injection. Furthermore,
in vivo microdialysis studies have shown that dialysate
cocaine concentrations obtained from brain tissue of chronic cocaine
treated rats approaches 3 µM after a cocaine challenge injection
(Pettit et al., 1990
). Moreover, this concentration of
cocaine approximates closely the brain concentrations of cocaine found
in users of the drug (Javaid et al., 1978
; Van Dyke et
al., 1978
). All cellular data are expressed as mean ± S.E.M.
Statistical analyses used in these studies were the unpaired one-tailed
Student's t test (SigmaPlot, Windows, Ver. 1.0).
Statistical significance was determined at the level of P
.05. Graphs and histograms were generated using SigmaPlot (Windows, Ver.1.0)
software (Jandel Scientific Corp., San Rafael, CA). In comparing groups
of small sample size (fig. 1, bottom) a Fisher exact test (Sigmastat,
Ver. 1.0) was used with statistical significance determined at the
level of P
.05.
| |
Results |
|---|
|
|
|---|
Expression of the COC-HYP is Dependent upon Duration of in Vivo Treatment
Cocaine (1-10 µM) applied by superfusion to brain slices
(n = 63) in vitro obtained from rats treated
chronically with cocaine in vivo [15 mg/kg, i.p., twice
daily (BID) × 14 or 28 days] resulted in a slow onset
hyperpolarization (COC-HYP) of the MP of DLSN neurons (at 3 µ M,
MP = -4.9 ± 0.4 mV, n = 10, fig.
1, top). We conclude that COC-HYPs are an
all-or-none event with a change of -2 mV from MP being the minimum
recorded threshold of occurrence. A change of -2 mV is also
biologically relevant, because at -60 mV a DLSN neuron could exhibit
spontaneous firing activity, whereas, at -62 mV the same DLSN neuron
would exhibit no spontaneous activity (Gallagher et al.,
1995
). All COC-HYPs were recorded in the presence of biogenic amine
antagonists in the superfusion medium.
|
While monitoring the incidence and concentration effect of an acute challenge with cocaine, we noted that COC-HYPs were observed in all rats having had a 14-day treatment regimen (fig. 1, bottom). Furthermore, the concentration of cocaine needed to record a consistent COC-HYP became less as the in vivo exposure was increased from 7 to 28 days of chronic cocaine treatment, i.e., the concentration-effect was shifted leftward (fig. 1, bottom). We conclude that a 14-day chronic cocaine regimen resulted in a "cellular sensitization" to an acute cocaine challenge.
We define the state of "cellular sensitization" to an acute cocaine
challenge as an increased incidence of observing a COC-HYP after a
challenge dose of cocaine (fig. 1, bottom). We observed that following
a 14- or 28-day chronic treatment regimen, a cocaine challenge of
3
µM would result in a hyperpolarization from every cell. Thus,
"cellular sensitization" represents an increase in the proportion
of DLSN neurons exhibiting a hyperpolarization to a cocaine challenge.
This conclusion is based on the application of the Fisher exact
probability test to the data depicted in figure 1, bottom. This
analysis demonstrates that there is no difference between the incidence
of observing a hyperpolarization after a cocaine challenge with the
three different concentrations of cocaine to neurons treated with
saline (control) or cocaine for 7 days. However, after a 14- or 28-day
treatment with cocaine there was a significant difference in the
incidence of observing a hyperpolarization when recording DLSN neurons
from rats receiving a saline (control) or treatment with cocaine for
only 7 days.
Non-Amine Mechanism of COC-HYP
Cocaine is well known for its ability to inhibit the transporters
responsible for the uptake of biogenic amines within the nervous system
(Goeders and Smith, 1986
; Ritz et al., 1987
). The DLSN contains postsynaptic receptors for each of the biogenic amines:
an alpha-2-adrenotropic receptor, a D-2-dopamine receptor and a 5HT-1A-serotonin receptor (for review see Gallagher et
al., 1995
). Cocaine and other biogenic amine uptake blockers
potentiate the hyperpolarizations recorded from DLSN neurons and
induced by exogenous application of these biogenic amines (Joëls
et al., 1987
; Simms and Gallagher, 1996
).
In an effort to minimize a potential endogenous biogenic amine-mediated
effect, we have included selective dopamine (DA) and norepinephrine
(NE) specific receptor antagonists (sulpiride, 1 µM, and idazoxan, 10 µM, respectively, Gallagher et al., 1995
) with all cocaine
challenges. These biogenic amine antagonists could also block the
activation of nerve terminal catecholamine receptors present on
glutamate, GABA or other terminals within the slice. Moreover, we
demonstrate that the COC-HYP (fig. 2A) persists when a brain slice is superfused with TTX (1 µM, fig. 2B),
and, in addition, persists in the presence of zero calcium medium with
TTX (fig. 2C). This combination of a voltage-dependent sodium channel
antagonist and lack of extracellular calcium will effectively block
synaptic transmission within the slice and eliminate action potential
dependent, but not spontaneous release of endogenous biogenic amines
and other endogenous neuroactive substances. The presence of TTX and
zero calcium medium would not alter non-vesicular release or release
mediated by reversal of the uptake carrier for GABA or other
transmitters, e.g., glutamate, on neurons or glia.
|
We have also conducted experiments with six rats, not previously
administered cocaine in vivo, but pretreated with
reserpine (5 mg/kg, 48 hr before death; Calabresi et
al., 1988
). When cocaine (3 µM) was applied to brain slices from
these reserpinized rats a 50% incidence of membrane hyperpolarizations
was observed. This 50% incidence is identical to that obtained with
nonreserpinized rats (fig. 1, bottom). These results add additional
support to the concept that a COC-HYP recorded from the DLSN is not
mediated by biogenic amines.
GABA Dependence of the COC-HYP
Antagonists were applied along with idazoxan (10 µM) and sulpiride (1 µM) to brain slices from rats treated chronically with cocaine. In conjunction with these two antagonists, the coapplication of the adenosine-1 receptor antagonist CPT (10 µM; n = 3), muscarinic antagonist atropine (1 µM; n = 3) or the 5-HT1A antagonist p-MPPF (1 µM; n = 3) did not alter the COC-HYP.
However, coapplication of bicuculline, a GABAA
receptor antagonist, which initially resulted in a depolarization of
the MP (Shoji et al., 1994
, 1997
), subsequently depressed a
typical COC-HYP. Similarly, application of a
GABAB receptor antagonist, CGP-55845A, also
initially resulted in a depolarization of the MP, but subsequently depressed a COC-HYP. Coapplication of both bicuculline and CGP-55845A suppressed but did not block completely the COC-HYP (fig.
3). A residual hyperpolarization
(1.3 ± 0.3 mV, n = 5) persisted, even in the
presence of both GABAA and
GABAB receptor antagonists.
|
Ionic mechanism of COC-HYP. Figure 1, top, 2A and 4A demonstrate the time required for onset and typical decrease of cellular input resistance associated with a COC-HYP. Note that a relatively long (5-10 min) continuous superfusion with cocaine is required to observe a COC-HYP. Shorter superfusion times were without effect. Figure 5A plots an estimation of the reversal potential of the COC-HYP. The apparent reversal potential for the COC-HYP obtained in this manner is -80 ± 1.4 mV (n = 5), a value not commonly attributed to a single ion. A combination of ions that could explain such a reversal potential is potassium and chloride, with EK ~-90 mV and ECl ~-70 mV in this preparation and extracellular media.
|
|
Blockade of COC-HYPs.
When extracellular chloride was
substituted with isethionate (117 mM) the COC-HYP was not observed
(fig. 4B; n = 4); a result suggesting that chloride ion
or a chloride-dependent process contributed significantly to the
COC-HYP. To investigate a possible role for chloride, we determined the
reversal potential of fast GABAA-receptor mediated f-IPSPs. F-IPSPs could be isolated by blocking excitatory transmission with a combination of CNQX (20 µ M) and D-AP5 (50 µ M); later, slower GABAB-receptor mediated IPSPs
were blocked with CGP-55845A (1 µM). Under these conditions, the
reversal potential of f-IPSPs in DLSN neurons from control brain slices
was -70.1 ± 0.5 mV, n = 14, although in brain
slices from rats administered cocaine chronically for 14 or 28 days,
the reversal potential of the f-IPSP was shifted in a statistically
significant manner (P
.05) to -67.4 ± 0.3 mV, n = 6. The reversal potential of the f-IPSP is equivalent to the reversal
or equilibrium potential for chloride ion (ECl-),
because the GABAA-ionotropic receptor is coupled
to a chloride (Cl
) channel. This shift in
the reversal potential for Cl
suggests
that the Cl
-pump, which maintains
Cl
concentrations across the cell
membrane, has been inhibited by the chronic cocaine treatment. An
inhibition of this outwardly directed pump would result in an elevation
of both intracellular chloride and sodium.
exchanger
that is essential for the GABA-transporter. Reduction of extracellular
sodium by replacement with glucosamine (117 mM) prevented the
expression of the COC-HYP (fig. 4C). This latter result, which is
similar to that observed with chloride replacement, suggests that, like
chloride, sodium is required
not necessarily as a charge carrier
but
primarily as a metabolic cofactor along with
Cl
, for the COC-HYP. Thus, at least,
potassium, chloride and sodium are necessary to observe the COC-HYP.
Temperature is an additional factor that is essential for the
generation of COC-HYPs in brains slices obtained from rats treated chronically with cocaine. Lowering the bath temperature from 34°C to
room temperature (22°C) prevented the appearance of COC-HYPs (fig.
4D). This result supports the hypothesis that the COC-HYP involves one
or more metabolically dependent phenomena.
GABA transport inhibitor, NO-711, blocks COC-HYP.
A process
that is metabolically dependent, sensitive to a lowering of
Na+ or Cl
, highly
active at GABA synapses, and persists in the presence of TTX and zero
calcium is GABA transport. Because cocaine inhibits biogenic amine
transporters, we considered the possibility that as a genetically
related protein (Uhl and Johnson, 1994
) the GABA transporter may also
be affected after chronic cocaine exposure.
|
| |
Discussion |
|---|
|
|
|---|
Previous intracellular electrophysiological results of cocaine
challenge in vitro after chronic cocaine in
vivo.
In only one other laboratory have intracellular
recording techniques been used to examine the actions of cocaine
in vitro with a brain slice preparation following chronic
cocaine in vivo (Harris and Williams, 1992
). In that study,
the effects of repeated cocaine (20 mg/kg/daily i.p., × 14 days) and a
1-wk withdrawal period were examined on norepinephrine neurons of rat
brain slices containing the locus ceruleus. No baseline changes of
synaptic transmission or electrical properties were noted before
reexposure to cocaine. However, neurons from animals administered
chronic cocaine exhibited a significant increase in sensitivity to the effects of cocaine which prolonged the time course of the NE-mediated inhibitory postsynaptic potential.
Superfusion of cocaine results in a GABA-dependent hyperpolarization within the DLSN. We have demonstrated in vitro with brain slices from rats treated chronically with cocaine in vivo, for 14 or 28 days that superfusion with cocaine (3 µM) results in a GABA-receptor dependent, biogenic amine independent, MP hyperpolarization of DLSN neurons. Support for the GABA dependence of this hyperpolarization stems from experiments that effectively reduced the COC-HYP; each experiment was conducted in the presence of biogenic amine antagonists. Each experiment points to a number of different mechanisms that may all contribute to the GABA-dependent COC-HYPs.
A combination of the GABAA-receptor antagonist, bicuculline (10 µM), with the GABAB-receptor antagonist, CGP-55845A (1 µM) depresses the COC-HYP (fig. 3). Neither antagonist alone is completely effective, although both antagonists, together are still not completely effective. The remaining residual hyperpolarization may be due to an electrogenic component of the GABA response that is resistant to receptor antagonism (Haugh-Scheidt et al., 1995
) across
the neuronal cell membrane. Both these ions are critical for the normal
functioning of the transporters for chloride and GABA. In this regard,
we have considered the possibility that chronic cocaine may affect the
Cl
- or GABA-transporters independently or
concomitantly, but in a manner analogous to its typical ability to
affect biogenic amine transporters, acutely. Indeed, the
GABA-transporters belong to one of two subfamilies of
Na+-and Cl
-dependent transporters whose genes encode glycoproteins with 12 putative transmembrane regions; the other subfamily includes the
biogenic monoamine transporters. These encoded glycoproteins act as
neurotransmitter/ion symporters that use transmembrane Na+ gradients to drive cellular accumulation of
their respective transmitters (Uhl and Johnson, 1994
. For instance, GABA accumulation (uptake and
reuptake) occurs with a Na+ gradient of (out > in) and/or a chloride gradient (out > in). As these ionic
gradients are shifted, they produce a net increase of intracellular
sodium, e.g., by inhibition of the chloride pump and
excessive activation of ionotropic glutamate receptors. The enhanced
activation of postsynaptic glutamate receptors could also include
activation of metabotropic receptors; these receptors are activated by
excessive glutamate release due to disinhibition of the nerve terminal
GABAB receptors (Shoji et al., 1997
|
A combination of mechanisms contribute to the expression of
COC-HYPs within the DLSN.
Our data suggest the following series of
events as a complex mechanism (fig. 7), which underlies the COC-HYP
recorded from DLSN neurons. An elevation of intracellular chloride
results from inhibition of an outwardly directed chloride pump
(Cl
-transporter). We provide data that
demonstrate a shift in the equilibrium potential of the
GABAA-receptor mediated f-ipsp. Elevation of
[Cl-I] is associated with
movement of Na+ into the cell to neutralize the
increased intracellular negativity brought about by
Cl
. Furthermore, an additional increase
of [Na+i] and possibly
[Ca++ i] results from
excessive activation of ionotropic glutamate receptors on DLSN neurons.
An excessive release of glutamate is due to a decreased efficacy
("down-regulated") of the GABA-heteroreceptor (fig. 7) on glutamate
releasing neurons (Shoji et al., 1997
). Our ability to block
the COC-HYP by lowering extracellular Na+ or
Cl
, and by lowering temperature both
support a cellular mechanism whereby chronic cocaine has resulted in
stimulation of the GABA-carrier (reversed transporter), such that when
a cocaine challenge is applied, GABA is secreted (released) from
neurons and/or glia resulting in a postsynaptic hyperpolarization
mediated by GABAA and GABAB
receptors.
perhaps in the
anatomical cascade of GABAergic efferents... ". Thus, based on our
data and the comments made by Wise, v.s., we propose that GABA transport inhibitors, by inhibiting the reversed transporters (GABA-carriers) activated by chronic cocaine, should be considered as
possible therapy for cocaine addiction.
| |
Acknowledgments |
|---|
The authors thank G. R. Hillman, Ph.D. for his expertise regarding statistical evaluation of the data.
| |
Footnotes |
|---|
Accepted for publication March 27, 1998.
Received for publication August 11, 1997.
1 This work was supported by National Institutes of Health, National Institutes of Drug Abuse Grant DA-07190 and Training Grant T32-DA07287
Send reprint requests to: Dr. Joel P. Gallagher, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555-1031.
| |
Abbreviations |
|---|
DLSN, dorsolateral septal nucleus;
COC-HYP, membrane hyperpolarization associated with cocaine challenge;
TTX, tetrodotoxin;
GABA,
-aminobutyric acid;
GABAA, GABAA receptor;
GABAB, GABAB
receptor;
COC-7, chronic in vivo 7-day, twice daily,
cocaine treatment;
COC-14, chronic in vivo 14-day, twice
daily, cocaine treatment;
COC-28, chronic in vivo
28-day, twice daily, cocaine treatment;
Ri, membrane input resistance;
f-ipsp, fast inhibitory synaptic potential;
s-ipsp, slow inhibitory
synaptic potential;
EPSP, excitatory postsynaptic potential;
CPT, 8-cyclopentyl-1, 3-dimethylxanthine;
ACSF, artificial cerebrospinal
fluid;
D-AP5, (D)-2-amino-5-phosphonovaleric
acid;
CNQX, cyano-7-nitroquinoxaline-2,3-dione;
MP, membrane potential;
DA, dopamine;
NE, norepinephrine;
5-HT, serotonin;
NIDA, National
Institute of Drug Abuse.
| |
References |
|---|
|
|
|---|
-aminobutyric acid and glutamate release by altering pre- not post-synaptic GABA-B receptors within the dorsolateral septal nucleus.
J Pharmacol Exp Ther
280:
129-137
-aminobutyric acid uptake inhibitor: Pharmacological characterization.
Eur J Pharmacol
223:
189-198.This article has been cited by other articles:
![]() |
C. A. Winstanley, Q. LaPlant, D. E. H. Theobald, T. A. Green, R. K. Bachtell, L. I. Perrotti, R. J. DiLeone, S. J. Russo, W. J. Garth, D. W. Self, et al. {Delta}FosB Induction in Orbitofrontal Cortex Mediates Tolerance to Cocaine-Induced Cognitive Dysfunction J. Neurosci., September 26, 2007; 27(39): 10497 - 10507. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Neugebauer, F. Zinebi, R. Russell, J. P. Gallagher, and P. Shinnick-Gallagher Cocaine and Kindling Alter the Sensitivity of Group II and III Metabotropic Glutamate Receptors in the Central Amygdala J Neurophysiol, August 1, 2000; 84(2): 759 - 770. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||